St. Jude Medical (STJ) Reports In-Line Q4 EPS; Issues Light Q1 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts STJ Hot Sheet
Join SI Premium – FREE
St. Jude Medical (NYSE: STJ) reported Q4 EPS of $1.03, in-line with the analyst estimate of $1.03. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.44 billion.
St. Jude Medical sees Q1 2015 EPS of $0.90-$0.92, versus the consensus of $0.97.
For earnings history and earnings-related data on St. Jude Medical (STJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- SLM (SLM) Misses Q3 EPS by 36c; lowers guidance
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
